Business Description
BeyondSpring Inc. is a New Jersey-based biopharmaceutical company focused on developing new treatments for cancer. Its most advanced drug, Plinabulin, has completed Phase III clinical trials and is being studied both as a cancer-fighting agent and as a way to reduce a common side effect of chemotherapy known as low white blood cell count. The company is also testing Plinabulin alongside other established cancer drugs and exploring a separate pipeline of early-stage molecules through its drug discovery platform. Founded in 2010, BeyondSpring continues to expand its research across multiple cancer types and treatment approaches.
